ArticleDiscover oncology2026
Explainable deep learning for skin cancer detection using swish-activated convolutional networks.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An Optimal Deep Hybrid Framework with Selective Kernel U-Net for Skin Lesion Detection and Classification.Bioengineering (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin cancer is among the most frequent and fatal illnesses in the world, but early and correct diagnosis is one of the main challenges because of the complicated visual patterns of skin lesions and the absence of interpretable diagnostic devices. Conventional techniques are largely based on experienced dermatologists, but manual inspection is time-consuming, subjective, and liable to misinterpretation, with high false positive outputs. To address these issues, we present a unique DCNN architecture that employs the Swish activation function to effectively identify complex patterns in the skin lesion dataset. This model has remarkable performance in diagnosing skin cancer, as evidenced by a 98.31% accuracy rate, a 98.12% precision rate, a 98.01% recall rate, and an F1-score of 98.09%. Utilising several localised and global explainable artificial intelligence (XAI) approaches, we evaluate the model's predictions to ensure transparency and reliability in medical contexts. To reconcile the disparity between AI research and its use in healthcare, our findings underscore the necessity of integrating deep learning with explainability. These XAI solutions tackle critical concerns such as inclusiveness, transparency, and error control, providing medical practitioners with a comprehensible and reliable framework for assessing the model's reasoning process. The suggested technique establishes a reliable mechanism to assist physicians in the early and precise identification of skin cancer, while enhancing diagnostic accuracy. Future studies will focus on enhancing the model's computational efficiency and incorporating more datasets to ensure its durability and fairness across various demographic groupings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.